This recognition underscores the FDA's acknowledgment of Powerful Medical's STEMI AI ECG Model, dubbed "Queen of Hearts", to ...

Cannabis use is associated with an increased risk for adverse cardiovascular events, including myocardial infarction (MI).

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Over 80% of these fatalities result from heart attacks and strokes. December is notorious for being the biggest month for heart attacks, with one of the most dangerous being the widowmaker heart ...

VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

Forensic pathologist Raquel Fortun shared a photo of a death certificate of a drug war victim which listed a peculiar cause ...

A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...

A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

A new study of 4.6 million people found that cannabis users were more likely to experience heart failure, strokes and cardiac ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.